Mesothelioma
Mesothelioma is a rare cancer that is caused almost exclusively by exposure to asbestos. It affects the thin, protective membrane surrounding the lungs, heart and abdominal cavity. An estimated 3,000 cases annually are diagnosed in the United States, and the majority of those are traced to an occupational exposure.
Although the use of asbestos has been reduced dramatically in recent decades, the incidence of mesothelioma has remained steady. It can take anywhere from 20 to 50 years after exposure to asbestos before obvious symptoms appear and a definitive diagnosis is made. While there still is no cure - and the prognosis is typically poor - significant progress has been made in recent years regarding treatment options and various alternative therapies.
How Asbestos Causes Mesothelioma
Mesothelioma cancer develops after exposure to asbestos, which most often occurs in the workplace –in industrial settings, shipyards, auto repair shops, old houses, schools and public buildings. It takes long-term exposure to make someone at risk, but heavy, short-term asbestos exposure has been known to cause mesothelioma cancer.
Microscopic asbestos fibers are breathed in or swallowed. The human body has difficulty destroying or getting rid of these fibers. Over decades, the fibers cause biological changes that result in inflammation, scarring and genetic damage. The most susceptible area to these fibers is the lining of the lungs, called the pleura, although fibers also can become trapped in the lining of the abdominal cavity (peritoneum). Once fibers cause biological damage, the stage is set for a 20- to 50-year latency period for mesothelioma to develop.
Types and Symptoms
How Mesothelioma is Diagnosed
Blood tests for mesothelioma are also available, but they do not confirm the presence of mesothelioma. Research and development is underway to determine if mesothelioma blood tests can aid in early diagnosis for at-risk former asbestos workers.
Staging
There are at least five systems that doctors use for the staging of pleural mesothelioma. Older systems like those created by Drs. Butchart and Sugarbaker did not classify tumors with tumor-node-metastasis (TNM) descriptors, so the International Mesothelioma Interest Group (IMIG) developed the detailed IMIG staging system in 1995. This system is the most widely used staging system for mesothelioma.Possible Areas Affected in Each IMIG Mesothelioma Stage
Mesothelioma Treatment
Treatment options for mesothelioma include surgery, chemotherapy and/or radiation therapy. Many mesothelioma doctors prefer to combine two or more of these treatments, an approach known as multimodal therapy. Clinical trials show this approach has improved survival rates.Palliative treatments that ease symptoms are quite common for patients of all stages. Experimental therapies like immunotherapy are showing progress for the future of mesothelioma treatment. Additionally, less traditional alternative treatments are available and widely touted by mesothelioma survivors.
Aucun commentaire:
Enregistrer un commentaire